TALLARIGO LORENZO
Insider CIK 1276039 · ICPT Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-07-07 | 2014-07-09 | 2,000 | — | $0 | 4,923 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-07-07 | 2014-07-09 | 1,000 | $244.00 | $244.0K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-07-07 | 2014-07-09 | 2,000 | $9.82 | $19.6K | 2,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-07-07 | 2014-07-09 | 1,000 | $242.11 | $242.1K | 1,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-05-09 | 2014-05-09 | 367 | — | $0 | 368 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-09 | 2014-05-09 | 367 | $232.00 | $85.1K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-05-09 | 2014-05-09 | 367 | — | $0 | 367 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-07 | 2014-05-09 | 1,000 | $260.76 | $260.8K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-05-07 | 2014-05-09 | 640 | $258.20 | $165.2K | 1,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | X Exercise deriv | 2014-04-10 | 2014-04-11 | 865,381 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | X Exercise | 2014-04-10 | 2014-04-11 | 865,381 | $10.40 | $9.00M | 6,485,576 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-04-10 | 2014-04-11 | 30,623 | $293.91 | $9.00M | 6,454,953 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-04-09 | 2014-04-11 | 318,695 | $320.00 | $101.98M | 5,620,195 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-02-10 | 2014-02-11 | 368 | $354.52 | $130.5K | 1,640 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-02-09 | 2014-02-11 | 368 | — | $0 | 735 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-02-09 | 2014-02-11 | 368 | — | $0 | 2,008 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-07 | 2014-01-09 | 1,839 | $67.41 | $124.0K | 1,640 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-11-09 | 2013-11-12 | 368 | — | $0 | 1,103 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-11-09 | 2013-11-12 | 368 | — | $0 | 3,479 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-21 | 2013-10-23 | 124,912 | $62.50 | $7.81M | 5,938,890 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-15 | 2013-10-17 | 1,123,415 | $62.50 | $70.21M | 6,063,802 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-10-10 | 2013-10-11 | 1,471 | — | $0 | 1,471 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-10-10 | 2013-10-11 | 1,471 | — | $0 | 3,111 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2013-05-07 | 2013-05-09 | 2,450 | — | $0 | 2,450 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2013-05-07 | 2013-05-09 | 1,640 | — | $0 | 1,640 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2012-11-16 | 2012-11-20 | 4,673 | — | $0 | 4,673 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2012-11-16 | 2012-11-20 | 2,942 | — | $0 | 2,942 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion deriv | 2012-10-16 | 2012-10-16 | 13,888,889 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion deriv | 2012-10-16 | 2012-10-16 | 13,888,889 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion deriv | 2012-10-16 | 2012-10-16 | 4,500,000 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion | 2012-10-16 | 2012-10-16 | 778,843 | — | $0 | 7,187,217 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion | 2012-10-16 | 2012-10-16 | 2,403,837 | — | $0 | 6,408,374 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion | 2012-10-16 | 2012-10-16 | 2,403,837 | — | $0 | 4,004,537 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | P Buy deriv | 2012-08-09 | 2012-10-16 | 4,500,000 | $2.00 | $9.00M | 4,500,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2012-07-31 | 2012-10-16 | 4,326 | — | $0 | 4,326 | SEC↗ |